Part Two:
What about proposing changes to ICD-11?
The
ICD-11 Reference Guide sets out what classes of change can be made and according to what time schedule.
A proposal to move an existing coded-for term from one parent to another or from one chapter to another would be considered a "Major Change" because it would require a code change; these types of consideration for change are on the longest time schedule in order to maintain the stability of the classification for global application.
ICD-11 Reference Guide:
Extract:
3.12 Annex A: ICD-11 Updating and Maintenance
"...The ICD-11 is being released in five-yearly ‘stable’ versions for international use (contains updates that impact on the four- and five- character structure), unless urgent public health needs require otherwise."
"Updates at a more detailed level than four- and five- characters can be published annually. Small error corrections that serve to clarify meaning, indexing or errors, may be communicated annually. Additions to the index can be done on an ongoing basis."
"All proposals are entered on an online maintenance platform, for verification of completeness, discussion and editing. The platform provides the infrastructure for routing proposals to reviewers and experts, and for providing feedback to the original authors. The maintenance platform also shows the final outcome of the proposal that has been entered in the authoring platform and become part of the ICD. Any individual user of the classification can submit a proposal for an update to the ICD. Such updates can refer to one or more entities of the ICD. They may address the position of entities in a tabular list, in the Foundation Component, and any element of the content model. The maintenance platform of ICD-11 (known as the ‘orange browser’) is used for proposals and comments. Any input to ICD-11 and its components requires proper referencing of sources, details of scientific evidence, and permission from the owner of any copyright materials (where applicable)."
"The proposals will be reviewed by scientific experts and classification experts*. The decision regarding the outcome of a particular proposal will be based on the recommendations by these experts."
*The WHO CSAC and MSAC committees which serve as ICD-11's update and revision committees.
In 2020, ICD-11 Development considered a proposal to relocate an existing block of terms (a parent class and all its child categories) under a different parent block and assign a secondary parent class.
WHO/ICD-11's response was:
"The ICD-11 codes are now frozen. Proposed changes to the classification that would result in a code change are not permitted. Changing the primary parent of this entity would result in this entity needing to have the code changed, as entities are assigned based on their primary location."
Team 2 WHO 2020-Feb-07 - 15:57 UTC
Potentially relocating PVFS; ME; CFS, IBS, Fibromyalgia or any other existing ICD-11 term from their current primary parent classes and reclassifying them under
6B60 Dissociative neurological symptom disorder (or under any other term) cannot be undertaken lightly by WHO/ICD-11, as such changes would constitute "Major Changes" which would result in disruption to the stability of the code structure, and can only be considered according to the revision schedule.
In June 2015, while ICD-11 was still under development, I had a conference call with Anneke Schmider
(then WHO Technical Officer, ICD Revision Project Manager) and Dr Robert Jakob
(WHO ICD classifications, ICD Revision Steering Group) in which Dr Jakob said he could be "crystal clear" that there is no proposal to classify the ICD-10 G93.3 legacy terms under the
Mental and behavioural disorders chapter.
Around 2016, Per Fink had lobbied WHO to include a special disorder section or create a new chapter within ICD-11 under which his BDS "functional disorders" (ME, CFS, IBS, Fibro and others) could be classified. WHO rejected his proposal:
In November 2017, Dr Tarun Dua and the (by that point stood down) Neurology Work Group proposed that "CFS" should be deleted from the neurology chapter and relocated under the
Symptoms, signs chapter under parent:
Symptoms, signs or clinical findings of the musculoskeletal system. That proposal was rejected by WHO/ICD-11 in November 2018.
In their rationale for their decision to reject, WHO stated that following completion of a literature review, they had concluded that
Postviral fatigue syndrome should remain the indexing target, that there was currently no evidence to suggest a better place to relocate these terms and that the terms would remain classified within the
Diseases of the nervous system chapter.
As I say, I'm not unduly concerned about them obtaining changes to ICD.
Edit: Minor edits for better clarity.